Obesidad, hábitos de vida y valoración FLI en la población laboral española durante la pandemia

  1. M.ª Teófila Vicente-Herrero 1
  2. M.ª Victoria Ramírez-Iñiguez de la Torre 1
  3. Ángel Arturo López González 1
  1. 1 Asociación Española de Especialistas en Medicina del Trabajo (AEEMT)
Journal:
Revista Clínica de Medicina de Familia

ISSN: 2386-8201

Year of publication: 2022

Volume: 15

Issue: 2

Pages: 93-98

Type: Article

DOI: 10.55783/RCMF.150205 DIALNET GOOGLE SCHOLAR lock_openOpen access editor

More publications in: Revista Clínica de Medicina de Familia

Sustainable development goals

Abstract

Background: non-alcoholic fatty liver disease is the most common liver disease globally. It is usually asymptomatic with a liver manifestation of metabolic syndrome. Aim: to estimate the risk of fatty liver by means of the FLI index and its relationship with BMI, adiposity indicators, lifestyle habits and socio-demographic variables. Material and methods: cross-sectional descriptive study in 815 workers aged 18-66 years during the health monitoring of companies taking part from March 2020-June 2021. The fatty liver index-FLI calculator was used and relationships were established with sociodemographic variables, adiposity indices, eating habits and physical activity using PREDIMED and IPAQ questionnaires. Results: FLI > 60 is significantly related to BMI, waist circumference and waist hip index. BMI increases the risk almost 20 times (odds ratio 19.87, 95% CI 10.84-36.44). Values are worse in men and risk increases with age. A medium to high FLI > 30 reveals a significant relationship with adherence to MedDiet and with physical activity performed. There are differences between the sexes (P < 0.0001). Conclusion: fatty liver risk increases with obesity and unhealthy lifestyle habits. Values are more unfavourable among men. It highlights the importance of evaluating adiposity indicators together with BMI.

€ View funding

Funding information

Funders

Bibliographic References

  • Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33. doi: 10.1186/1471-230X-6-33
  • Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33. doi: 10.1186/1471-230X-6-33
  • Bosserhoff A, Hellerbrand C. Obesity and fatty liver are 'grease' for the machinery of hepatic fibrosis. Dig Dis. 2011;29(4):377-83. doi: 10.1159/000329800.
  • Chung TH, Kim JK, Kim JH, Lee YJ. Fatty Liver Index as a Simple and Useful Predictor for 10-year Cardiovascular Disease Risks Determined by Framingham Risk Score in the General Korean Population. J Gastrointestin Liver Dis. 2021;30:221-6. doi: 10.15403/jgld-3404
  • Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381-95. doi: 10.1249/01.MSS.0000078924.61453.FB
  • Domingo-Salvany A, Bacigalupe A, Carrasco JM, Espelt A, Ferrando J, Borrell C. Propuestas de clase social neoweberiana y neomarxista a partir de la Clasificación Nacional de Ocupaciones 2011. Gac Sanit [Internet]. 2013 [consultado el 7 de septiembre de 2021];27(3):263-72. Disponible en: https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0213-91112013000300013
  • Fracanzani AL, Valenti L, Bugianesi E, Vanni E, Grieco A, Miele L, et al. Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity. J Hepatol. 2011;54(6):1244-9. doi: 10.1016/j.jhep.2010.09.037
  • Guo W, Lu J, Qin P, Li X, Zhu W, Wu J, et al. The triglyceride-glucose index is associated with the severity of hepatic steatosis and the presence of liver fibrosis in non-alcoholic fatty liver disease: a cross-sectional study in Chinese adults. Lipids Health Dis. 2020;19(1):218. doi: 10.1186/s12944-020-01393-6
  • Huang X, Xu M, Chen Y, Peng K, Huang Y, Wang P, et al. Validation of the Fatty Liver Index for Nonalcoholic Fatty Liver Disease in Middle-Aged and Elderly Chinese. Medicine (Baltimore). 2015;94(40):e1682. doi: 10.1097/MD.0000000000001682
  • Jiang J, Torok N. Nonalcoholic steatohepatitis and the metabolic syndrome. Metab Syndr Relat Disord. 2008;6(1):1-7. doi: 10.1089/met.2007.0026
  • Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al.; Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41(6):1313-21. doi: 10.1002/hep.20701
  • Milić S, Lulić D, Štimac D. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations. World J Gastroenterol. 2014;20(28):9330-7. doi: 10.3748/wjg.v20.i28.9330
  • Ministerio de Educación y Formación Profesional. Subsecretaria de Educación y Formación Profesional. Organización del sistema educativo. [Internet.] Madrid: MEFP; 2022. Disponible en: https://administracion.gob.es/pag_Home/Tu-espacio-europeo/derechos-obligaciones/ciudadanos/educacion/sistema-educativo/organizacion.html
  • Motamed N, Sohrabi M, Ajdarkosh H, Hemmasi G, Maadi M, Sayeedian FS, et al. Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease. World J Gastroenterol. 2016;22(10):3023-30. doi: 10.3748/wjg.v22.i10.3023
  • Narankiewicz D, Ruiz-Nava J, Buonaiuto V, Ruiz-Moreno MI, López-Carmona MD, Pérez-Belmonte LM, et al. Utility of Liver Function Tests and Fatty Liver Index to Categorize Metabolic Phenotypes in a Mediterranean Population. Int J Environ Res Public Health. 2020;17(10):3518. doi: 10.3390/ijerph17103518
  • Organización Mundial de la Salud. Body mass index – BMI. [Internet.] Copenhagen: OMS; 2020. Disponible en: https://www.euro.who.int/en/health-topics/disease-prevention/nutrition/a-healthy-lifestyle/body-mass-index-bmi
  • Ostovaneh MR, Zamani F, Ansari-Moghaddam A, Sharafkhah M, Saeedian FS, Rohani Z, et al. Nonalcoholic Fatty Liver: The Association with Metabolic Abnormalities, Body Mass Index and Central Obesity--A Population-Based Study. Metab Syndr Relat Disord. 2015;13(7):304-11. doi: 10.1089/met.2014.0131
  • Pang Q, Zhang JY, Song SD, Qu K, Xu XS, Liu SS, Liu C. Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index. World J Gastroenterol. 2015;21(5):1650-62. doi: 10.3748/wjg.v21.i5.1650
  • Petta S, Amato MC, Di Marco V, Cammà C, Pizzolanti G, Barcellona MR, et al. Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2012;35(2):238-47. doi: 10.1111/j.1365-2036.2011.04929.x
  • Raszeja-Wyszomirska J, Szymanik B, Ławniczak M, Kajor M, Chwist A, Milkiewicz P, Hartleb M. Validation of the BARD scoring system in Polish patients with nonalcoholic fatty liver disease (NAFLD). BMC Gastroenterol. 2010;10:67. doi: 10.1186/1471-230X-10-67
  • Ros E. The PREDIMED study. Endocrinol Diabetes Nutr. 2017;64(2):63-6. English, Spanish. doi: 10.1016/j.endinu.2016.11.003
  • Takahashi S, Tanaka M, Higashiura Y, Mori K, Hanawa N, Ohnishi H, Furuhashi M. Prediction and validation of nonalcoholic fatty liver disease by fatty liver index in a Japanese population. Endocr J. 2022;69(4):463-471. doi: 10.1507/endocrj.EJ21-0563
  • Torres DM, Harrison SA. Noninvasive methods of assessing nonalcoholic fatty liver disease: what the clinician needs to know. Clin Gastroenterol Hepatol. 2013;11(9):1205-7. doi: 10.1016/j.cgh.2013.05.040.
  • Vicente-Herrero MT, Ramírez-Iñiguez de la Torre MV, Capdevila García L, Partida-Hanon A, Reinoso-Barbero L, López González AA. Prevalence of overweight and obesity in Spanish working population along the Covid-19 pandemic. Adiposity indicators and related variables. Acad J Health Sci. 2022;37(2):132-8.
  • Vongsuvanh R, George J, McLeod D, van der Poorten D. Visceral adiposity index is not a predictor of liver histology in patients with non-alcoholic fatty liver disease. J Hepatol. 2012;57(2):392-8. doi: 10.1016/j.jhep.2012.03.013
  • Ye Q, Zou B, Yeo YH, Li J, Huang DQ, Wu Y, et al. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020 Aug;5(8):739-752. doi: 10.1016/S2468-1253(20)30077-7
  • Zelber-Sagi S, Webb M, Assy N, Blendis L, Yeshua H, Leshno M, et al. Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification. World J Gastroenterol. 2013;19(1):57-64. doi: 10.3748/wjg.v19.i1.57
  • Zhou J, Zhou F, Wang W, Zhang XJ, Ji YX, Zhang P, et al. Epidemiological Features of NAFLD From 1999 to 2018 in China. Hepatology. 2020 May;71(5):1851-1864. doi: 10.1002/hep.31150
Data source: Dialnet